A Pharmacokinetic Evaluation of Levonorgestrel Implant and Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-infected Ugandan Women

Trial Profile

A Pharmacokinetic Evaluation of Levonorgestrel Implant and Non-nucleoside Reverse Transcriptase Inhibitor (NNRTI)-Based Antiretroviral Therapy in HIV-infected Ugandan Women

Completed
Phase of Trial: Phase II

Latest Information Update: 06 Apr 2016

At a glance

  • Drugs Levonorgestrel (Primary) ; Efavirenz; Nevirapine
  • Indications HIV-1 infections; Pregnancy
  • Focus Pharmacokinetics
  • Acronyms LNG-NNRTI PK
  • Most Recent Events

    • 31 Mar 2016 Status changed from active, no longer recruiting to completed, according to ClinicalTrials.gov record.
    • 08 Dec 2015 Results published in the Clinical Infectious Diseases
    • 11 Feb 2014 Status changed to active, no longer recruiting according to ClinicalTrials.gov record .
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top